A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Clinical trial NCT02227784 · TERMINATED
Trial details
- NCT number
- NCT02227784
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-12-01
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.